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OBJECTIVEdThe increasing burdens of obesity and diabetes are two of the most prominent
threats to the health of populations of developed and developing countries alike. The Central
America Diabetes Initiative (CAMDI) is the first study to examine the prevalence of diabetes in
Central America.
RESEARCH DESIGN ANDMETHODSdThe CAMDI survey was a cross-sectional sur-
vey based on a probabilistic sample of the noninstitutionalized population of five Central Amer-
ican populations conducted between 2003 and 2006. The total sample population was 10,822,
of whom 7,234 (67%) underwent anthropometry measurement and a fasting blood glucose or
2-h oral glucose tolerance test.
RESULTSdThe total prevalence of diabetes was 8.5%, but was higher in Belize (12.9%) and
lower in Honduras (5.4%). Of the screened population, 18.6% had impaired glucose tolerance/
impaired fasting glucose.
CONCLUSIONSdAs this population ages, the prevalence of diabetes is likely to con-
tinue to rise in a dramatic and devastating manner. Preventive strategies must be quickly
introduced.
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Apparent changes in access to cheap,energy-dense food, urbanization,and adoption of sedentary lifestyles
in the countries of Central America have
raised concerns about the rapid emergence
of obesity and diabetes in the region.
Diabetes and related chronic conditions
in Central America have been largely ne-
glected by epidemiologic and surveillance
programs in recent decades, however, be-
cause other issues, such as under-nutrition,
infectious diseases, and armed conflict,
were regarded as much more pressing
health threats.
TheCentral AmericaDiabetes Initiative
(CAMDI) is the first population-based mul-
tinational study to examine the prevalence of
diabetes and risk factors in Central America.
We report here the main findings from the
multinational analyses of this survey.
RESEARCH DESIGN AND
METHODSdThe CAMDI survey was a
cross-sectional survey based on a proba-
bilistic, stratified, multistage, cluster sam-
pling design of the noninstitutionalized
population of five Central American sites.
The survey sampled included the entire
national population in Belize; the overall
metropolitan populations in San Jose,
Costa Rica; Tegucigalpa, Honduras; and
Managua, Nicaragua; and was restricted to
the municipalities of Santa Tecla and Villa
Nueva, which are part of the metropolitan
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areas of San Salvador and Guatemala City,
respectively.
In each city, the primary sampling
unit was a cluster of independent house-
holds within predetermined geographic
areas. The primary sampling units were
grouped into geographic strata (sectors and
compact segments or blocks). The sample
was allocated proportionally to the size of
the population within each geographic
stratum of each city. All eligible individuals
aged 20 years or older in the randomly
selected households were invited to partic-
ipate. Data were weighted to account for
differential selection probabilities and sur-
vey nonresponse, and weights were post-
stratified to the adult population of each
site based on age group and sex. The total
sample population was 10,822, of whom
7,234 (66.8%) underwent anthropometry
measurement and laboratory tests. Data
were weighted to represent the population
of the sampled city, except in Belize, where
data were weighted to the country’s entire
population. The sample represented more
than 2 million inhabitants of the selected
sites (Table 1).
Participants were requested to fast
overnight the day they came to the exam-
ination center. Venous blood samples
were collected in sodium fluoride tubes
before and 2 h after a glucose load (75 g of
anhydrous glucose). The cold chain was
kept until the plasma was separated (2 to
4 h after extraction) and the correspond-
ing analysis was done the same day or the
next day. Glucose was determined by
standard enzymatic methods. Except in
El Salvador, laboratory tests included
fasting blood glucose (FBG) and a 2-h
oral glucose tolerance test (OGTT). In El
Salvador, only fasting glucose was deter-
mined through a capillary blood sample
tested in a HemoCue glucose analyzer
(HemoCue AB, Ängelholm, Sweden) that
reports plasma equivalent values.
The prevalence of undiagnosed diabe-
tes was calculated using the blood sample
weights and defined as FBG $126 mg/dL
or 2-h OGTT$200mg/dL. The total prev-
alence of diabetes was calculated by com-
bining participants with diagnosed
diabetes (interview weights) and all partic-
ipantswhose diabetes statuswas assessed by
the blood sample (blood sample weights).
Intermediate hyperglycemia was defined as
impaired fasting glucose (IFG; FBG .100
and,126mg/dL), or impaired glucose tol-
erance (IGT, 2-h glucose.140 and,200
mg/dL). Prevalence rates were standardized
by the direct method using the World Segi
Population (1) as standard.
RESULTSdSixty percent of partici-
pants were young adults (20–39 years),
31.6% were middle aged (40–64 years),
and only 8.4% were elderly ($65 years;
Table 1). Respondents’ mean BMI was
27.1 6 0.2 kg/m2.
The total prevalence of diabetes across
the six sites was 8.5%, but was notably
higher in Belize (12.9%) and notably lower
in Honduras (5.4%). Men and women had
similar prevalence except in Belize, where
women had a higher prevalence (17.6%)
than men (8.8%). Overall, 40% of those
with diabetes were undiagnosed, ranging
from 53% in Honduras to 28% in Costa
Rica. The prevalence of intermediate hy-
perglycemia varied more across the sites
than diabetes. Of the screened population,
18.6% had intermediate hyperglycemia,
with the highest prevalence reported in
Guatemala (28.2%) and the lowest in
Nicaragua (12.4%).
CONCLUSIONSdThis report is the
first epidemiologic study of the preva-
lence of diabetes in Central America to be
based on a representative geographic
sample.We found a combined prevalence
of diabetes of 8.5% for the six-country
region. Almost half of the cases of diabetes
were undiagnosed.
The combined crude prevalence of
diabetes in participating sites was compa-
rable to the prevalence of 9.6% reported
in the U.S. (2) (estimates for 1988–2006)
(3) and 8.4% in Mexico City (4) in 2000,
and higher than the prevalence of 7.2%
reported in four Bolivian cities in 1998
(5). The prevalence of diabetes in Belize
was comparable to the 12.5% reported in
Jamaica (6) in 1999 and New York in
2008 (7). The Cardiovascular Risk Factor
Multiple Evaluation in Latin America
(CARMELA) study reported the preva-
lence of diabetes was 4.4% in Lima and
8.9% in Mexico City (8). The proportion
of cases of diagnosed diabetes in the com-
bined sample (5%) was comparable to
that reported in the U.S. (5%) in 2000
and in Bolivia (5.2%) in 1998. The propor-
tion of undiagnosed cases of diabetes was
higher in Belize and Managua than in the
other sites.
These prevalence estimates are partic-
ularly worrisome given the relative youth of
the population. The overall age-adjusted
prevalence is equivalent to the most recent
9.6% estimate from the U.S. (1988–2006)
(2), with site-specific prevalence ranging
from 7% in Tegucigalpa to 15% in Belize.
This increased prevalence may be a related
to a variety of characteristics, including ge-
netic, demographic, and lifestyle factors,
but the prevalence of obesity across the
sites, and in particular among Belizean
(44%) and Nicaraguan women (34%;
data not shown in Table 1), was as high
or higher than the most recent U.S. esti-
mate of 35.5% among adult women (9).
The age-adjusted prevalence of di-
abetes was comparable among men and
women in all sites except in Belize, where
the prevalence of diagnosed and undiag-
nosed diabetes was more than twice
as high among women (10.5% and 7.1%,
respectively) than in men (4.7% and 3.6%,
respectively). Although a full explanation
of this issue merits further investigation
of diabetes-related genetic and environ-
mental risk factors, our data showed that
theprevalenceof obesity (BMI.29kg/m2), a
major risk factor for diabetes, was almost
twice as high among Belizean women
(44.1%) as among Belizean men (23.6%;
data not shown in Table 1). In general,
the prevalence of obesitywas higher among
women than inmen across all CAMDI sites,
but the sex difference in the prevalence of
obesity observed in Belize was the greatest.
In summary, the total prevalence of
diabetes found in the combined Central
America sample was greater than the
prevalence reported in most Latin Amer-
ican countries and similar to that in the
U.S. These findings are particularly note-
worthy given the relatively young age of
the population of Central America and
the potential for a growing burden in fu-
ture decades. These findings should be an
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impetus to develop effective prevention
and control strategies in the region.
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